Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
CXA1
Gap junction alpha-1 protein |
2 |
2 |
High-throughput |
0.584 | High |
|
EPN1
Epsin-1 |
1 |
1 |
Small-scale |
0.561 | High |
|
GRM7
Metabotropic glutamate receptor 7 |
1 |
2 |
Small-scale |
0.561 | High |
|
ITM2B
Integral membrane protein 2B |
1 |
9 |
High-throughput |
0.536 | High |
|
NCAM1
Neural cell adhesion molecule 1 |
1 |
2 |
Small-scale |
0.501 | High |
|
MAP1A
Microtubule-associated protein 1A |
1 |
13 |
Small-scale |
0.501 | High |
|
MLP3B
Microtubule-associated proteins 1A/1B light chain 3B |
1 |
20 |
Small-scale |
0.501 | High |
|
MLP3A
Microtubule-associated proteins 1A/1B light chain 3A |
1 |
20 |
Small-scale |
0.501 | High |
|
AKAP1
A-kinase anchor protein 1, mitochondrial |
1 |
4 |
Small-scale |
0.481 | High |
|
ATX3
Ataxin-3 |
1 |
5 |
Small-scale |
0.479 | High |
|
PARK7
Parkinson disease protein 7 homolog |
1 |
2 |
High-throughput |
0.479 | High |
|
GRIA4
Glutamate receptor 4 |
1 |
8 |
Small-scale |
0.479 | High |
|
DPYL2
Dihydropyrimidinase-related protein 2 |
1 |
13 |
Small-scale |
0.479 | High |
|
SUMO3
Small ubiquitin-related modifier 3 |
1 |
7 |
High-throughput |
0.479 | High |
|
EPN2
Epsin-2 |
1 |
1 |
Small-scale |
0.479 | High |
|
SCNAA
Sodium channel protein type 10 subunit alpha |
1 |
3 |
Small-scale |
0.457 | High |
|
GCR
Glucocorticoid receptor |
1 |
16 |
Small-scale |
0.445 | High |
|
GLUT4
Solute carrier family 2, facilitated glucose transporter member 4 |
1 |
2 |
High-throughput |
0.445 | High |
|
DYL1
Dynein light chain 1, cytoplasmic |
1 |
3 |
Small-scale |
0.445 | High |
|
RAC1
Ras-related C3 botulinum toxin substrate 1 |
1 |
13 |
Small-scale |
0.445 | High |
|
UBC
Polyubiquitin-C [Cleaved into: Ubiquitin; Ubiquitin-related] |
1 |
11 |
High-throughput |
0.437 | High |
|
CCG8
Voltage-dependent calcium channel gamma-8 subunit |
1 |
0 |
Small-scale |
0.232 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024